It is estimated that secondary metabolites generated by plants and microbes have contributed to the development in as much as 75% of the treatments available for cancer and infectious diseases. The existing natural product pharmaceutical discovery and manufacturing segment is based on products derived from plant materials or fermentation of terrestrial microorganisms. The oceans contain tremendous potential for the discovery of new drugs, which have remained virtually untapped. In targeting novel marine compounds, Triton is able to exploit the incredible structural complexity and biological activity of these molecules in the production of new drugs.
In the past, logistical and technical difficulties posed significant barriers to sourcing natural products from the marine environment. However, further advancements in the technologies using self-contained underwater breathing apparatus allow us to access great underwater depths and remote regions, to explore sources of diverse animal, plant and microbial life. Further advances in genetics, fermentation techniques and synthesis allow Triton to provide solutions to sustainable production and lead optimization of these novel resources. Triton offers unique scientific expertise in the discovery and isolation of marine natural products for sustainable and cost-effective production of drug leads.
Please contact us for details in regards to expanding the diversity of your drug discovery platform, or partnering and licensing opportunities of Triton’s diverse portfolio of drug leads.